Literature DB >> 20829049

Expression of hepatocyte growth factor in the serum and cerebrospinal fluid of patients with Parkinson's disease.

Zivar Salehi1, Farzad Rajaei.   

Abstract

Hepatocyte growth factor (HGF), also known as scatter factor, promotes the survival and migration of immature neurons. The HGF receptor c-Met is expressed in neurons. HGF plays an important role as a neurotrophic factor in the brain. HGF is produced by a wide variety of cells and is found in many physiological fluids, including serum and cerebrospinal fluid (CSF). Since CSF is in contact with the extracellular space of the brain, biochemical brain modifications are, to some extent, reflected in the CSF, and peptide and growth factors in the CSF can be used as biomarkers of disease. In this study, CSF and serum HGF concentrations were measured in patients with Parkinson's disease. The study population comprised 33 patients with Parkinson's disease and 38 normal controls. Western blot analysis using an anti-HGF antibody confirmed the presence of HGF in serum and CSF. No significant changes in serum HGF were observed in this study. However, CSF HGF expression was higher in patients with Parkinson's disease than in controls (p < 0.001). This finding indicates that HGF may be involved in the pathophysiology of Parkinson's disease.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20829049     DOI: 10.1016/j.jocn.2010.04.034

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  6 in total

1.  Differentiation of hUC-MSC into dopaminergic-like cells after transduction with hepatocyte growth factor.

Authors:  Jin-Feng Li; Hong-Lei Yin; Adam Shuboy; Hai-Feng Duan; Ji-Yu Lou; Jing Li; Hong-wei Wang; Yun-Liang Wang
Journal:  Mol Cell Biochem       Date:  2013-06-05       Impact factor: 3.396

2.  The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system.

Authors:  Caroline C Benoist; Leen H Kawas; Mingyan Zhu; Katherine A Tyson; Lori Stillmaker; Suzanne M Appleyard; John W Wright; Gary A Wayman; Joseph W Harding
Journal:  J Pharmacol Exp Ther       Date:  2014-09-03       Impact factor: 4.030

3.  Importance of the brain Angiotensin system in Parkinson's disease.

Authors:  John W Wright; Joseph W Harding
Journal:  Parkinsons Dis       Date:  2012-11-07

4.  Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation.

Authors:  Alexandra Dumitriu; Jeanne C Latourelle; Tiffany C Hadzi; Nathan Pankratz; Dan Garza; John P Miller; Jeffery M Vance; Tatiana Foroud; Thomas G Beach; Richard H Myers
Journal:  PLoS Genet       Date:  2012-06-28       Impact factor: 5.917

5.  Human umbilical cord mesenchymal stem cells infected with adenovirus expressing HGF promote regeneration of damaged neuron cells in a Parkinson's disease model.

Authors:  Xin-Shan Liu; Jin-Feng Li; Shan-Shan Wang; Yu-Tong Wang; Yu-Zhen Zhang; Hong-Lei Yin; Shuang Geng; Hui-Cui Gong; Bing Han; Yun-Liang Wang
Journal:  Biomed Res Int       Date:  2014-09-03       Impact factor: 3.411

6.  Curcumin-Activated Mesenchymal Stem Cells Derived from Human Umbilical Cord and Their Effects on MPTP-Mouse Model of Parkinson's Disease: A New Biological Therapy for Parkinson's Disease.

Authors:  Yun-Liang Wang; Xin-Shan Liu; Shan-Shan Wang; Peng Xue; Zhi-Lei Zeng; Xiao-Peng Yang; Si-Miao Zhang; Wei Zheng; Linlin Hua; Jin-Feng Li; Hai-Tao Wang; Shang Guo
Journal:  Stem Cells Int       Date:  2020-02-17       Impact factor: 5.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.